Hosted on MSN
Signs and Symptoms of a Fungal Sinus Infection
A fungal sinus infection, also called fungal sinusitis, is when fungus causes an infection of the sinuses. The sinuses are air-filled cavities in the head that produce mucus (snot), which drains out ...
Most people are familiar with bacterial sinus infections that come with seasonal colds or allergies, but another, potentially more serious type of infection often goes unrecognized until it causes ...
The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis (AFRS) with a ...
Verywell Health on MSN
Sinus infections and what causes them
This can lead to blocked drainage, causing pain, pressure, and other symptoms.TypesSinus infections are categorized by the ...
The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis (AFRS) and a ...
A new research perspective was published in Oncoscience (Volume 10) on May 27, 2023, entitled, "Think outside the box – atypical infections in chronic sinusitis." Inflammations of the paranasal ...
What Is Dupixent, and Why Does It Matter? Dupixent (dupilumab) is a prescription medicine for treating various allergic conditions and is given as a shot under the skin. The FDA has now approved ...
Dupilumab significantly reduced sinus opacification, symptoms, and the need for corticosteroids and improved quality of life in patients with allergic fungal rhinosinusitis (AFRS), findings from a ...
Allergic fungal rhinosinusitis can be a severe, recalcitrant condition, but it has an expanding treatment base. The condition is characterized by thick eosinophilic mucus, nasal polyps, and high ...
Patients receiving dupilumab showed clinical improvement in nasal congestion and smell, and were less likely to require systemic corticosteroids or additional sino-nasal surgery. The Food and Drug ...
The FDA approved dupilumab (Dupixent) for treating allergic fungal rhinosinusitis, a first for the condition, the agency announced on Wednesday. Approval stipulates use in individuals 6 years and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results